Guo, Y., Cao, Q., Hong, Z. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Med Res 7, 11 (2020). https://doi.org/10.1186/s40779-020-00240-0
Khan, A., Benthin, C., Zeno, B., Albertson, T. E., Boyd, J., Christie, J. D., ... & Hardes, K. (2017). A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Critical Care, 21(1), 234.
Li, Wenhui et al. “Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.” Nature vol. 426,6965 (2003): 450-4. doi:10.1038/nature02145
Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J., Pfeffer, M. A., & Solomon, S. D. (2020). Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. The New England journal of medicine, NEJMsr2005760. Advance online publication. https://doi.org/10.1056/NEJMsr2005760
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C. L., Abiona, O., ... & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 367(6483), 1260-1263.
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science, 367(6485), 1444-1448.
